VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

BriaCell Therapeutics Corp. (BCTX) Total Return Calculator with Dividends Reinvested

BriaCell Therapeutics Corp.

Popular:

The total return for BriaCell Therapeutics Corp. (BCTX) stock is -87.46% over the past 12 months. So far it's down 42.82% this year. The 5-year total return is -99.17%, meaning $10,000 invested in BCTX stock 5 years ago would be worth $83 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in BCTX 1 year ago, it would be worth $1,289 today — you'd have lost $8,711.

With Dividends Reinvested$1,289-87.11%

Price Only (No DRIP)$1,289-87.11%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in BCTX

1Y$1,254-$8,746 (-87.5%)-87.5% CAGR

3Y$38-$9,962 (-99.6%)-84.4% CAGR

5Y$83-$9,917 (-99.2%)-61.7% CAGR

BriaCell Therapeutics Corp. did not pay dividends during this period. Total return = price return.

Loading BCTX total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-42.82%	—	-42.82%	—	$5,718
1Y	-87.46%	-87.46%	-87.46%	—	$1,254
3Y	-99.62%	-84.41%	-99.62%	—	$38
5Y	-99.17%	-61.66%	-99.17%	—	$83

Risk & Highlights

Best Year+98.56%2021

Worst Year-100.00%2018

Max Drawdown-91.05%2025-05-20 → 2026-02-24

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-46.72%	-46.72%	—	+0.41%	-47.1pp
2025	-91.83%	-91.83%	—	+16.64%	-108.5pp
2024	-89.41%	-89.41%	—	+24.00%	-113.4pp
2023	+27.45%	+27.45%	—	+24.81%	+2.6pp
2022	-49.83%	-49.83%	—	-19.95%	-29.9pp

BCTX underperformed the S&P 500 by 117.83pp over the past year (-87.46% vs +30.37%).

Loading summary...

BCTX Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
BCTXBriaCell Therapeutics Corp.	$5M	-7.4%	-42.8%	-87.5%	—	-99.6%	-99.2%	—
NKTRNektar Therapeutics	$1.7B	+9.4%	+92.0%	+818.2%	—	+621.8%	-72.3%	-59.1%
IMVTImmunovant, Inc.	$5.5B	+10.6%	+5.1%	+96.1%	—	+40.9%	+62.4%	+173.6%
ADCTADC Therapeutics S.A.	$478M	+1.1%	+6.8%	+196.1%	—	+77.4%	-84.1%	-87.3%
CRISCuris, Inc.	$76M	+4.9%	-41.1%	-72.0%	—	-96.4%	-99.7%	-99.7%
HALOHalozyme Therapeutics, Inc.	$7.7B	+2.5%	-7.3%	-7.1%	—	+115.3%	+37.0%	+570.7%
IOVAIovance Biotherapeutics, Inc.	$1.3B	+6.9%	+40.9%	+13.4%	—	-49.9%	-87.6%	-34.3%
NUVLNuvalent, Inc.	$7.5B	+0.1%	+1.5%	+53.5%	—	+171.2%	+446.1%	+446.1%
FATEFate Therapeutics, Inc.	$280M	+111.3%	+145.5%	+143.0%	—	-55.4%	-96.8%	+40.5%
AGENAgenus Inc.	$132M	-7.6%	+16.1%	+27.1%	—	-88.2%	-93.9%	-94.3%
IMCRImmunocore Holdings plc	$1.6B	-4.2%	-9.4%	+2.3%	—	-48.9%	-24.0%	-29.1%

Compare:BCTX vs NKTR BCTX vs IMVT BCTX vs ADCT BCTX vs NKTR vs IMVT

About BCTX Dividend Returns

BriaCell Therapeutics Corp. (BCTX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of BCTX over the past year?

BriaCell Therapeutics Corp. (BCTX) delivered a return of -87.46% over the past year. Since BCTX does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in BCTX be worth today?

A $10,000 investment in BriaCell Therapeutics Corp. one year ago would be worth $1,254 today, representing a loss of $8,746.

Q3Does BCTX pay dividends?

BriaCell Therapeutics Corp. (BCTX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For BCTX, the total return equals the price-only return.

Q4Did BCTX beat the S&P 500?

No, BriaCell Therapeutics Corp. (BCTX) underperformed the S&P 500 by 117.83 percentage points over the past year. BCTX delivered a total return of -87.46%, compared to the S&P 500's 30.37%. This means a passive S&P 500 index fund outperformed BCTX by 117.83pp during this period.

Q5What is BCTX's worst drawdown?

BriaCell Therapeutics Corp. (BCTX) experienced a maximum drawdown of -91.05% over the past year, declining from its peak on 2025-05-20 to its trough on 2026-02-24. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is BCTX's long-term total return over 10, 20, or 30 years?

Use the period buttons above (10Y, 15Y, 20Y, 30Y) to see BriaCell Therapeutics Corp.'s long-term total return with dividends reinvested. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends. The "If You Invested" section shows exactly how a lump-sum investment would have grown over each period.

Q7What was BCTX's best and worst year?

BriaCell Therapeutics Corp.'s best calendar year was 2021 with a total return of 98.6%. Its worst year was 2018 with a total return of -100.0%. This range shows the volatility investors should expect — the difference between the best and worst year is 198.6 percentage points.